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approach.12 Recent data also show that the use of broad
spectrum intrapartum antibiotics might increase the
incidence of necrotising enterocolitis.13 Guidelines
should therefore seek to minimise the overall number
of women exposed. This study provides data that will
aid the development of such guidelines in the United
Kingdom.
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Role of endogenous oestrogen in aetiology of coronary
heart disease: analysis of age related trends in coronary
heart disease and breast cancer in England and Wales
and Japan
Debbie A Lawlor, Shah Ebrahim, George Davey Smith
The sex difference in mortality from coronary heart
disease decreases with increasing age, suggesting a
protective effect of oestrogen in premenopausal
women. This decrease is, however, the result of a decel›
eration in death rates in men, with no change in rates
in women around the age of menopause.1 The age
specific rate of breast cancer—a condition associated
with endogenous oestrogen—does show a change
around the age of menopause among women in the
United States.2 The relatively low rates of coronary
heart disease in premenopausal women may make it
difficult to detect an effect of the menopause.3 Rates of
breast cancer among Japanese women are low. If low
rates of coronary heart disease around the time of the
menopause explain the lack of an effect of the
menopause on age related trends then no effect of the
menopause on breast cancer trends among Japanese
women might be expected.
Methods and results
We obtained data on age specific mortality from
coronary heart disease (ICD›9 (international classifi›
cation of diseases, 9th revision): 410›414) for women
and men and from breast cancer (ICD›9: 174) for
women in England and Wales from the Office for
National Statistics and in Japan from the World Health
Organization. We calculated five year aggregate rates
for each country (1994›8 for England and Wales and
1993›7 for Japan) and plotted them on a semilogarith›
mic scale.
Coronary heart disease mortality in women from
both countries increased with age, and in both
countries the death rate in men decelerated at older
ages, reducing the magnitude of the sex difference (fig›
ure). We found no inflection in age specific mortality
from coronary heart disease in women around the age
of menopause in either England and Wales or Japan. In
contrast, mortality from breast cancer began to
decelerate around the time of the menopause in both
groups.
Comment
Mortality from breast cancer in Japanese women is
about half that from coronary heart disease in women
in England and Wales at ages 45›54; it is thus unlikely
that the low mortality from coronary heart disease
makes detection of a menopause effect difficult. The
inflection in breast cancer mortality occurs over a nar›
row age range, suggesting that if effects of menopausal
oestrogen on coronary heart disease occurred they too
should operate over a similar range and be observable.
However, coronary heart disease is associated with sev›
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eral environmental risk factors, and if the effect of oes›
trogen on risk of coronary heart disease is small
relative to other risk factors then any effect of the
menopause may be masked.
Witteman et al argue that age related trends in cor›
onary heart disease mortality are not inconsistent with
an effect of the menopause.4 They used simulation
models based on levels of risk of coronary heart
disease in men to estimate age related trends in
“women who never experience a menopause.”4 Such
analyses are unrealistic and unhelpful.
Work on the aetiology of coronary heart disease in
women has been dominated by the idea that oestrogen
plays an important part and is responsible for the sex
difference at younger ages. The implications of this are
that higher rates of coronary heart disease in men are
seen as inevitable and that postmenopausal hormone
replacement therapy has become the mainstay of cor›
onary heart disease prevention in women. We
conclude that environmental factors are the most
important determinants of coronary heart disease in
women and men and of the difference in coronary
heart disease rates between women and men.5
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Mortality from liver disease in the West Midlands,
1993›2000: observational study
N C Fisher, J Hanson, A Phillips, J N Rao, E T Swarbrick
Advanced liver failure carries a poor prognosis, and its
prevalence may be reflected by mortality statistics in
the form of death certifications for liver disease. In the
United Kingdom mortality from cirrhosis and other
liver diseases increased slowly from the 1970s to the
early 1990s.1 We aimed to ascertain the current
mortality from liver disease in the West Midlands
region of the United Kingdom.
Methods and results
The study was set in three adjacent metropolitan
boroughs in the West Midlands with a total population
of 837 000. Around 8.4% of residents are of south
Asian origin (Indian, Pakistani, or Bangladeshi; 1991
census). Deaths from liver disease were identified from
public health mortality files supplied by the Office for
National Statistics, which we searched using ICD›9
(international classification of diseases, 9th revision)
reference codes 570›573, and from files supplied by
the registrar of the local health authority. South Asian
origin and religion were identified from subjects’
names. In cases of deaths from liver disease of unspeci›
fied cause (ICD 571.5 and related codes) we analysed
case notes to search for underlying causative factors.
Crude mortality from primary liver disease
increased from 6.0 per 100 000 population in 1993 to
12.7/100 000 in 2000 (figure). The increase was almost
exclusively the result of alcoholic liver disease (ICD
codes 571.0›571.3), which increased almost threefold
from 2.8/100 000 in 1993 to 8.0/100 000 in 2000
(regression coefficient +0.89/100 000/year, 95% confi›
dence interval 0.57 to 1.21), although it seemed to have
stabilised from 1998 onwards. Rates of increase in
deaths from alcoholic liver disease were similar for
white men, white women, and Asian men. Asian men
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